Business Description
Shanghai Medicilon Inc
ISIN : CNE100003NQ8
Share Class Description:
SHSE:688202: Class ACompare
Compare
Traded in other countries / regions
688202.China IPO Date
2019-11-05Description
Shanghai Medicilon Inc is a comprehensive biomedical research and developemnt service company. It provides a full range of one-stop new drug development services for pharmaceutical companies and research institutions around the world in line with domestic and international reporting standards.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.33 | |||||
| Equity-to-Asset | 0.75 | |||||
| Debt-to-Equity | 0.18 | |||||
| Debt-to-EBITDA | 2.7 | |||||
| Interest Coverage | 20.84 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 4.38 | |||||
| Beneish M-Score | -1.54 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 42.8 | |||||
| 3-Year EBITDA Growth Rate | 55.7 | |||||
| 3-Year EPS without NRI Growth Rate | 50.1 | |||||
| 3-Year FCF Growth Rate | -104.8 | |||||
| 3-Year Book Growth Rate | 17.2 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 26.34 | |||||
| 9-Day RSI | 28.51 | |||||
| 14-Day RSI | 32.12 | |||||
| 6-1 Month Momentum % | -36.96 | |||||
| 12-1 Month Momentum % | -63.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.89 | |||||
| Quick Ratio | 2.67 | |||||
| Cash Ratio | 1.48 | |||||
| Days Inventory | 60.23 | |||||
| Days Sales Outstanding | 144.67 | |||||
| Days Payable | 66.79 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.2 | |||||
| Dividend Payout Ratio | 0.25 | |||||
| Forward Dividend Yield % | 1.2 | |||||
| 5-Year Yield-on-Cost % | 1.19 | |||||
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | -5.78 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 31.46 | |||||
| Operating Margin % | 12.56 | |||||
| Net Margin % | 10.93 | |||||
| FCF Margin % | -17.65 | |||||
| ROE % | 9.46 | |||||
| ROA % | 6.68 | |||||
| ROIC % | 10.5 | |||||
| ROC (Joel Greenblatt) % | 13.63 | |||||
| ROCE % | 9.21 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 22.84 | |||||
| PE Ratio without NRI | 20.44 | |||||
| PEG Ratio | 0.46 | |||||
| PS Ratio | 2.48 | |||||
| PB Ratio | 1.63 | |||||
| Price-to-Tangible-Book | 1.83 | |||||
| Price-to-Operating-Cash-Flow | 241.85 | |||||
| EV-to-EBIT | 20.24 | |||||
| EV-to-EBITDA | 20.24 | |||||
| EV-to-Revenue | 2.28 | |||||
| EV-to-FCF | -12.96 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.52 | |||||
| Price-to-Graham-Number | 1.31 | |||||
| Price-to-Net-Current-Asset-Value | 3.31 | |||||
| Price-to-Net-Cash | 17.32 | |||||
| Earnings Yield (Greenblatt) % | 4.94 | |||||
| FCF Yield % | -6.48 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shanghai Medicilon Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,601.825 | ||
| EPS (TTM) (Â¥) | 1.419 | ||
| Beta | 1.84 | ||
| Volatility % | 44.35 | ||
| 14-Day RSI | 32.12 | ||
| 14-Day ATR (Â¥) | 2.280275 | ||
| 20-Day SMA (Â¥) | 39.1315 | ||
| 12-1 Month Momentum % | -63.29 | ||
| 52-Week Range (Â¥) | 31.39 - 127.714285 | ||
| Shares Outstanding (Mil) | 134.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shanghai Medicilon Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shanghai Medicilon Inc Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shanghai Medicilon Inc Frequently Asked Questions
What is Shanghai Medicilon Inc(SHSE:688202)'s stock price today?
The current price of SHSE:688202 is ¥32.41. The 52 week high of SHSE:688202 is ¥127.71 and 52 week low is ¥31.39.
When is next earnings date of Shanghai Medicilon Inc(SHSE:688202)?
The next earnings date of Shanghai Medicilon Inc(SHSE:688202) is .
Does Shanghai Medicilon Inc(SHSE:688202) pay dividends? If so, how much?
The Dividend Yield %  of Shanghai Medicilon Inc(SHSE:688202) is 1.2% (As of Today), Highest Dividend Payout Ratio of Shanghai Medicilon Inc(SHSE:688202) was 0.39. The lowest was 0.14. And the median was 0.27. The  Forward Dividend Yield % of Shanghai Medicilon Inc(SHSE:688202) is 1.2%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers